Prefrontal expectancy and reinforcement-driven antidepressant placebo effects.

Area of Science:

• Neuroscience
• Psychiatry
• Psychology

Background:

• Placebo responses in depression highlight the influence of expectancies and appraisals on mood.
• Cognitive and neural mechanisms of placebo effects in depression remain poorly understood.
• Experimental challenges include simulating antidepressant effects and manipulating mood.

Purpose of the Study:

• To investigate the cognitive and neural mechanisms of antidepressant placebo effects.
• To develop and validate an experimental paradigm for manipulating mood-related expectancies.
• To explore the role of the lateral prefrontal cortex (lPFC) and opioid system in placebo responses.

Main Methods:

• Developed an acute antidepressant placebo experiment using intravenous "fast-acting antidepressant" infusion and sham fMRI neurofeedback.
• Twenty volunteers with major depression participated, rating expected and actual mood improvement.
• Utilized mixed-effects analyses to examine trial-by-trial expectancy and mood ratings, and fMRI data.

Main Results:

• "Drug" infusion cues increased expectancies of mood improvement.
• Both "drug" infusion and sham neurofeedback induced reported mood improvement.
• Greater sham neurofeedback magnitude recruited the lateral prefrontal cortex (lPFC); higher lPFC response correlated with stronger placebo effects and expectancy modulation.
• Peripheral β-endorphin levels and depressive symptomatology moderated behavioral placebo effects.

Conclusions:

• Demonstrated the feasibility of manipulating antidepressant placebo expectancies and their reinforcement.
• Provided initial insights into the lPFC's role in placebo-induced expectancies and mood.
• Offered preliminary evidence for the opioid system's involvement in antidepressant placebo effects.